BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 12684681)

  • 1. Trichostatin inhibits the growth of ACHN renal cell carcinoma cells via cell cycle arrest in association with p27, or apoptosis.
    Park WH; Jung CW; Park JO; Kim K; Kim WS; Im YH; Lee MH; Kang WK; Park K
    Int J Oncol; 2003 May; 22(5):1129-34. PubMed ID: 12684681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monensin inhibits the growth of renal cell carcinoma cells via cell cycle arrest or apoptosis.
    Park WH; Jung CW; Park JO; Kim K; Kim WS; Im YH; Lee MH; Kang WK; Park K
    Int J Oncol; 2003 Apr; 22(4):855-60. PubMed ID: 12632079
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arsenic trioxide-mediated growth inhibition in MC/CAR myeloma cells via cell cycle arrest in association with induction of cyclin-dependent kinase inhibitor, p21, and apoptosis.
    Park WH; Seol JG; Kim ES; Hyun JM; Jung CW; Lee CC; Kim BK; Lee YY
    Cancer Res; 2000 Jun; 60(11):3065-71. PubMed ID: 10850458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monensin-mediated growth inhibition in NCI-H929 myeloma cells via cell cycle arrest and apoptosis.
    Park WH; Kim ES; Kim BK; Lee YY
    Int J Oncol; 2003 Jul; 23(1):197-204. PubMed ID: 12792794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monensin-mediated growth inhibition of SNU-C1 colon cancer cells via cell cycle arrest and apoptosis.
    Park WH; Kim ES; Jung CW; Kim BK; Lee YY
    Int J Oncol; 2003 Feb; 22(2):377-82. PubMed ID: 12527937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silibinin upregulates the expression of cyclin-dependent kinase inhibitors and causes cell cycle arrest and apoptosis in human colon carcinoma HT-29 cells.
    Agarwal C; Singh RP; Dhanalakshmi S; Tyagi AK; Tecklenburg M; Sclafani RA; Agarwal R
    Oncogene; 2003 Nov; 22(51):8271-82. PubMed ID: 14614451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide inhibits the growth of A498 renal cell carcinoma cells via cell cycle arrest or apoptosis.
    Hyun Park W; Hee Cho Y; Won Jung C; Oh Park J; Kim K; Hyuck Im Y; Lee MH; Ki Kang W; Park K
    Biochem Biophys Res Commun; 2003 Jan; 300(1):230-5. PubMed ID: 12480548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trichostatin A inhibits proliferation and induces expression of p21WAF and p27 in human brain tumor cell lines.
    Wang ZM; Hu J; Zhou D; Xu ZY; Panasci LC; Chen ZP
    Ai Zheng; 2002 Oct; 21(10):1100-5. PubMed ID: 12508652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Silymarin and silibinin cause G1 and G2-M cell cycle arrest via distinct circuitries in human prostate cancer PC3 cells: a comparison of flavanone silibinin with flavanolignan mixture silymarin.
    Deep G; Singh RP; Agarwal C; Kroll DJ; Agarwal R
    Oncogene; 2006 Feb; 25(7):1053-69. PubMed ID: 16205633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lovastatin-induced inhibition of HL-60 cell proliferation via cell cycle arrest and apoptosis.
    Park WH; Lee YY; Kim ES; Seol JG; Jung CW; Lee CC; Kim BK
    Anticancer Res; 1999; 19(4B):3133-40. PubMed ID: 10652602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
    Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R
    Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of trichostatin A, a histone deacetylase inhibitor, on the regulation of apoptosis in H-ras-transformed breast epithelial cells.
    Park H; Lee YJ; Kim TH; Lee J; Yoon S; Choi WS; Myung CS; Kim HS
    Int J Mol Med; 2008 Nov; 22(5):605-11. PubMed ID: 18949380
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of trichostatin A, a histone deacetylase inhibitor, on glioma proliferation in vitro by inducing cell cycle arrest and apoptosis.
    Wetzel M; Premkumar DR; Arnold B; Pollack IF
    J Neurosurg; 2005 Dec; 103(6 Suppl):549-56. PubMed ID: 16383255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1.
    Rosato RR; Almenara JA; Grant S
    Cancer Res; 2003 Jul; 63(13):3637-45. PubMed ID: 12839953
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of trichostatin A as a potential candidate for anticancer therapy in non-small-cell lung cancer.
    Mukhopadhyay NK; Weisberg E; Gilchrist D; Bueno R; Sugarbaker DJ; Jaklitsch MT
    Ann Thorac Surg; 2006 Mar; 81(3):1034-42. PubMed ID: 16488717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxisome proliferator-activated receptor gamma ligands induce cell cycle arrest and apoptosis in human renal carcinoma cell lines.
    Yang FG; Zhang ZW; Xin DQ; Shi CJ; Wu JP; Guo YL; Guan YF
    Acta Pharmacol Sin; 2005 Jun; 26(6):753-61. PubMed ID: 15916743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 2,4-dinitrophenol induces G1 phase arrest and apoptosis in human pulmonary adenocarcinoma Calu-6 cells.
    Han YH; Kim SW; Kim SH; Kim SZ; Park WH
    Toxicol In Vitro; 2008 Apr; 22(3):659-70. PubMed ID: 18276104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased acetylation of histone H3 in renal cell carcinoma: a potential target of histone deacetylase inhibitors.
    Kanao K; Mikami S; Mizuno R; Shinojima T; Murai M; Oya M
    J Urol; 2008 Sep; 180(3):1131-6. PubMed ID: 18639283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trichostatin A, an inhibitor of histone deacetylases, strongly suppresses growth of pancreatic adenocarcinoma cells.
    Donadelli M; Costanzo C; Faggioli L; Scupoli MT; Moore PS; Bassi C; Scarpa A; Palmieri M
    Mol Carcinog; 2003 Oct; 38(2):59-69. PubMed ID: 14502645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-CD26 monoclonal antibody-mediated G1-S arrest of human renal clear cell carcinoma Caki-2 is associated with retinoblastoma substrate dephosphorylation, cyclin-dependent kinase 2 reduction, p27(kip1) enhancement, and disruption of binding to the extracellular matrix.
    Inamoto T; Yamochi T; Ohnuma K; Iwata S; Kina S; Inamoto S; Tachibana M; Katsuoka Y; Dang NH; Morimoto C
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3470-7. PubMed ID: 16740772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.